<div class="govuk-grid-row">
  <div class="govuk-grid-column-two-thirds">
    <div class="gem-c-title govuk-!-margin-top-8 govuk-!-margin-bottom-8">
    <p class="gem-c-title__context">
      Guidance
    </p>
  <h1 class="gem-c-title__text gem-c-title__text--long">
    Updates to packaging components and instructions on submissions if the UK leaves the EU without a deal for those marketing authorisations (MA) issued following conversion of EU MA
  </h1>
</div>
  </div>
  
  <div class="govuk-grid-column-two-thirds">
    
  <p class="gem-c-lead-paragraph">What companies will need to do to register new artwork for medicines packaging as a result of new marketing authorisations being issued  ina no-deal Brexit.</p>

  </div>
</div>

<div class="govuk-grid-row">
  <div class="metadata-logo-wrapper">
    <div class="govuk-grid-column-two-thirds metadata-column">
        <div class="app-c-publisher-metadata" lang="en">
    <div class="app-c-published-dates " lang="en">
    Published 21 March 2019
    <br></br>Last updated 2 April 2019
      — <a href="#history" class="app-c-published-dates__history-link govuk-link">see all updates</a>
</div>

      <div class="app-c-publisher-metadata__other">
        <dl data-module="track-click">
            <dt class="app-c-publisher-metadata__term">
              From:
            </dt>
            <dd class="app-c-publisher-metadata__definition" data-module="gem-toggle">
                <span class="app-c-publisher-metadata__definition-sentence">
                  <a class="govuk-link" href="/government/organisations/medicines-and-healthcare-products-regulatory-agency">Medicines and Healthcare products Regulatory Agency</a>
                </span>
            </dd>
        </dl>
      </div>
  </div>

    </div>
    <div class="govuk-grid-column-one-third">
    </div>
  </div>
</div>




<div class="govuk-grid-row">
  <div class="govuk-grid-column-two-thirds">
    

      <div id="contents" class="app-c-contents-list-with-body" data-module="sticky-element-container">
      <div class="responsive-bottom-margin">
          <nav class="gem-c-contents-list  gem-c-contents-list--no-underline " role="navigation" data-module="track-click">
      <h2 class="gem-c-contents-list__title">Contents</h2>

    <ol class="gem-c-contents-list__list">
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--dashed">
          <a class="gem-c-contents-list__link govuk-link " data-track-category="contentsClicked" data-track-action="content_item 1" data-track-label="#actions-to-take-once-you-have-been-issued-an-ma" data-track-options="{"dimension29":"Actions to take once you have been issued an MA\n"}" href="#actions-to-take-once-you-have-been-issued-an-ma">Actions to take once you have been issued an MA
</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--dashed">
          <a class="gem-c-contents-list__link govuk-link " data-track-category="contentsClicked" data-track-action="content_item 2" data-track-label="#multi-language-packs" data-track-options="{"dimension29":"Multi-language packs"}" href="#multi-language-packs">Multi-language packs</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--dashed">
          <a class="gem-c-contents-list__link govuk-link " data-track-category="contentsClicked" data-track-action="content_item 3" data-track-label="#national-mas-granted-after-a-mutual-recognition-or-decentralised-procedure" data-track-options="{"dimension29":"National MAs granted after a mutual recognition or decentralised procedure"}" href="#national-mas-granted-after-a-mutual-recognition-or-decentralised-procedure">National MAs granted after a mutual recognition or decentralised procedure</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--dashed">
          <a class="gem-c-contents-list__link govuk-link " data-track-category="contentsClicked" data-track-action="content_item 4" data-track-label="#submission-and-best-practice" data-track-options="{"dimension29":"Submission and best practice"}" href="#submission-and-best-practice">Submission and best practice</a>

        </li>
    </ol>
</nav>
      </div>
    
      
<div class="gem-c-govspeak govuk-govspeak direction-ltr" data-module="govspeak">
      <div class="govspeak">
<div class="call-to-action">
<h3 id="stay-up-to-date">Stay up to date</h3>

<p>The UK will leave the <abbr title="European Union">EU</abbr> on 31 October. This page tells you how to prepare for Brexit. It will be updated if anything changes, including if a deal is agreed.</p>

<p><a href="https://www.gov.uk/email-signup/?topic=/government/brexit">Sign up to email alerts</a> to get the latest information</p>
</div>

<p>Once you have been issued with your new Marketing Authorisation (<abbr title="marketing authorisation">MA</abbr>), you have 21 months to establish and register a UK presence for your <abbr title="marketing authorisation">MA</abbr>. This will include submitting amended artwork for approval to accommodate the following new administrative information:</p>

<ul>
  <li>name and address of Marketing Authorisation Holder (<abbr title="Marketing Authorisation Holder">MAH</abbr>) or representative</li>
  <li>UK <abbr title="marketing authorisation">MA</abbr> number</li>
  <li>name and address of product manufacturer for batch release</li>
</ul>

<h2 id="actions-to-take-once-you-have-been-issued-an-ma">Actions to take once you have been issued an <abbr title="marketing authorisation">MA</abbr>
</h2>

<p>You will have a further 12 months (33 months in total from exit day) to ensure all stock released to market is in compliant packaging. This additional time allows for assessment of your submission(s) and time for implementation in the production schedule.</p>

<p>You may need to amend the labelling and/or the patient information leaflet (<abbr title="patient information leaflet">PIL</abbr>) to take account of new information as a result of a variation between the grant of the new <abbr title="marketing authorisation">MA</abbr> and 21 months from when Brexit takes place. In such cases, the changed artwork which accompanies that variation application should include the new administrative information at that earlier time.</p>

<p>If you are making changes to the labelling and/or the <abbr title="patient information leaflet">PIL</abbr> as a consequence of a variation application, you should submit the full colour mock-ups as part of the variation submission. These will be assessed and approved as part of the variation procedure. Normal fee arrangements apply.</p>

<p>If you are only changing the name and address of the marketing authorisation and/or the manufacturer for batch release (stated in the <abbr title="patient information leaflet">PIL</abbr>) you may do this as part of a <a href="https://www.gov.uk/guidance/medicines-packaging-labelling-and-patient-information-leaflets#notification-scheme-registration">Better Regulation of Medicines Initiative, <abbr title="Better Regulation of Medicines Initiative">BROMI</abbr> notification</a>. Normal fee arrangements apply.</p>

<p>If you are making any other changes to the statutory information or the pack design (which are not consequential to a change to the Summary of Product Characteristics (<abbr title="Summary of Product Characteristics">SmPC</abbr>)), you will need to submit the artwork for full assessment to the Product Information Quality Unit under change code P2. Normal fee arrangements apply.</p>

<h2 id="multi-language-packs">Multi-language packs</h2>

<p>The <abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr> will continue to allow multi-country packs, including packs with more than one language on the pack and/or in the <abbr title="patient information leaflet">PIL</abbr>, provided that the entirety of the information is compliant with the UK requirements.</p>

<h2 id="national-mas-granted-after-a-mutual-recognition-or-decentralised-procedure">National <abbr title="marketing authorisations">MAs</abbr> granted after a mutual recognition or decentralised procedure</h2>

<p><abbr title="marketing authorisations">MAs</abbr> previously the subject of a mutual recognition or decentralised submission will be considered as purely national licences. Changes to packaging components which previously may have been suitable for submission via an MR 61(3) submission will now be considered under the national rules.</p>

<p>In many cases these changes will be suitable for self-certification under the <abbr title="Better Regulation of Medicines Initiative">BROMI</abbr> scheme.  Some changes, however, will need to be submitted for full assessment.</p>

<p>See our information on <a href="https://www.gov.uk/guidance/medicines-packaging-labelling-and-patient-information-leaflets">submission categories, best practice guidelines and the fees which apply</a>.</p>

<h2 id="submission-and-best-practice">Submission and best practice</h2>

<p>Full details on <a href="https://www.gov.uk/guidance/medicines-packaging-labelling-and-patient-information-leaflets">how to submit applications for assessment, national best practice guidance and the fees</a>.</p>

<p>This guidance will apply from exit day in line with the Human Medicines Regulations (Amendment etc.) (<abbr title="European Union">EU</abbr> Exit) Regulations 2019.
This guidance follows on from the further guidance note published on 3 January 2019</p>

</div>
</div>


      <div class="responsive-bottom-margin">
        <div class="app-c-published-dates app-c-published-dates--history" id="history" data-module="toggle" lang="en">
    Published 21 March 2019
    <br></br>Last updated 2 April 2019
      <a href="#full-history" class="app-c-published-dates__toggle govuk-link" data-controls="full-history" data-expanded="false" data-toggled-text="- hide all updates">+ show all updates</a>
      <div class="app-c-published-dates__change-history js-hidden" id="full-history">
        <ol>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2019-04-02T14:18:25.000+01:00">2 April 2019</time>
              Minor amendment to strengthen the description of steps companies need to take in order to register new artwork for medicines packaging.
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2019-03-21T10:32:00.000+00:00">21 March 2019</time>
              First published.
            </li>
        </ol>
      </div>
</div>

      </div>

      <div data-sticky-element class="app-c-contents-list-with-body__link-wrapper">
        <div class="app-c-contents-list-with-body__link-container">
          <a class="govuk-link app-c-back-to-top dont-print" href="#contents">
    <svg class="app-c-back-to-top__icon" xmlns="http://www.w3.org/2000/svg" width="13" height="17" viewbox="0 0 13 17">
      <path fill="currentColor" d="M6.5 0L0 6.5 1.4 8l4-4v12.7h2V4l4.3 4L13 6.4z"></path>
    </svg>
    Contents
</a>

        </div>
      </div>
  </div>
  </div>
  
<div class="govuk-grid-column-one-third">
  
<div class="gem-c-contextual-sidebar">

    
  <div class="gem-c-related-navigation">

      <h2 id="related-nav-related_items-68f469f1" class="gem-c-related-navigation__main-heading" data-track-count="sidebarRelatedItemSection">
        Related content
      </h2>




      <nav role="navigation" class="gem-c-related-navigation__nav-section" aria-labelledby="related-nav-related_items-68f469f1" data-module="gem-toggle">


  <ul class="gem-c-related-navigation__link-list" data-module="track-click">


        <li class="gem-c-related-navigation__link"><a class="gem-c-related-navigation__section-link gem-c-related-navigation__section-link--sidebar  gem-c-related-navigation__section-link--other" data-track-category="relatedLinkClicked" data-track-action="1.1 Related content" data-track-label="/guidance/guidance-note-on-new-assessment-routes-in-a-no-deal-scenario" data-track-options="{"dimension28":"5","dimension29":"Guidance note on new assessment routes in a no-deal Brexit"}" href="/guidance/guidance-note-on-new-assessment-routes-in-a-no-deal-scenario">Guidance note on new assessment routes in a no-deal Brexit</a></li>
        <li class="gem-c-related-navigation__link"><a class="gem-c-related-navigation__section-link gem-c-related-navigation__section-link--sidebar  gem-c-related-navigation__section-link--other" data-track-category="relatedLinkClicked" data-track-action="1.2 Related content" data-track-label="/guidance/guidance-on-registration-of-clinical-trials-for-investigational-medicinal-products-and-publication-of-summary-results" data-track-options="{"dimension28":"5","dimension29":"Guidance on registration of clinical trials for investigational medicinal products and publication of summary results in a no-deal Brexit"}" href="/guidance/guidance-on-registration-of-clinical-trials-for-investigational-medicinal-products-and-publication-of-summary-results">Guidance on registration of clinical trials for investigational medicinal products and publication of summary results in a no-deal Brexit</a></li>
        <li class="gem-c-related-navigation__link"><a class="gem-c-related-navigation__section-link gem-c-related-navigation__section-link--sidebar  gem-c-related-navigation__section-link--other" data-track-category="relatedLinkClicked" data-track-action="1.3 Related content" data-track-label="/government/publications/conversion-of-community-marketing-authorisations-to-uk-marketing-authorisations-letter-to-industry" data-track-options="{"dimension28":"5","dimension29":"Conversion of Community Marketing Authorisations to UK Marketing Authorisations – letters to industry"}" href="/government/publications/conversion-of-community-marketing-authorisations-to-uk-marketing-authorisations-letter-to-industry">Conversion of Community Marketing Authorisations to UK Marketing Authorisations – letters to industry</a></li>
        <li class="gem-c-related-navigation__link"><a class="gem-c-related-navigation__section-link gem-c-related-navigation__section-link--sidebar  gem-c-related-navigation__section-link--other" data-track-category="relatedLinkClicked" data-track-action="1.4 Related content" data-track-label="/government/publications/conversion-of-existing-approved-community-marketing-authorisations-to-uk-marketing-authorisations-mas-letter-to-industry-and-guidance" data-track-options="{"dimension28":"5","dimension29":"Conversion of existing approved Community Marketing Authorisations to UK Marketing Authorisations (MAs) – letter to industry"}" href="/government/publications/conversion-of-existing-approved-community-marketing-authorisations-to-uk-marketing-authorisations-mas-letter-to-industry-and-guidance">Conversion of existing approved Community Marketing Authorisations to UK Marketing Authorisations (MAs) – letter to industry</a></li>
        <li class="gem-c-related-navigation__link"><a class="gem-c-related-navigation__section-link gem-c-related-navigation__section-link--sidebar gem-c-related-navigation__section-link--inline  gem-c-related-navigation__section-link--other" data-track-category="relatedLinkClicked" data-track-action="1.5 Related content" data-track-label="/guidance/medicines-get-scientific-advice-from-mhra" data-track-options="{"dimension28":"5","dimension29":"Medicines: get scientific advice from MHRA"}" href="/guidance/medicines-get-scientific-advice-from-mhra">Medicines: get scientific advice from MHRA</a></li>

  </ul>
</nav>



      <nav role="navigation" class="gem-c-related-navigation__nav-section" aria-labelledby="related-nav-collections-68f469f1" data-module="gem-toggle">

    <h3 id="related-nav-collections-68f469f1" class="gem-c-related-navigation__sub-heading gem-c-related-navigation__sub-heading--sidebar" data-track-count="sidebarRelatedItemSection">Collection</h3>

  <ul class="gem-c-related-navigation__link-list" data-module="track-click">


        <li class="gem-c-related-navigation__link"><a class="gem-c-related-navigation__section-link gem-c-related-navigation__section-link--sidebar" data-track-category="relatedLinkClicked" data-track-action="2.1 Collection" data-track-label="/government/collections/mhra-guidance-and-publications-on-a-possible-no-deal-scenario" data-track-options="{"dimension28":"1","dimension29":"MHRA guidance and publications about a possible no-deal Brexit"}" href="/government/collections/mhra-guidance-and-publications-on-a-possible-no-deal-scenario">MHRA guidance and publications about a possible no-deal Brexit</a></li>

  </ul>
</nav>

  </div>


</div>

</div>

</div>


  <div class="govuk-grid-row">
    <div class="govuk-grid-column-two-thirds">
        
  <div class="gem-c-contextual-footer">
    
  <div class="gem-c-related-navigation">





      <nav role="navigation" class="gem-c-related-navigation__nav-section" aria-labelledby="related-nav-topics-69b5dfa0" data-module="gem-toggle">

    <h2 id="related-nav-topics-69b5dfa0" class="gem-c-related-navigation__sub-heading gem-c-related-navigation__sub-heading--footer" data-track-count="footerRelatedItemSection">Explore the topic</h2>

  <ul class="gem-c-related-navigation__link-list" data-module="track-click">


        <li class="gem-c-related-navigation__link"><a class="gem-c-related-navigation__section-link gem-c-related-navigation__section-link--footer" data-track-category="relatedLinkClicked" data-track-action="1.1 Explore the topic" data-track-label="/topic/medicines-medical-devices-blood/marketing-authorisations-variations-licensing" data-track-options="{"dimension28":"1","dimension29":"Marketing authorisations, variations and licensing guidance"}" href="/topic/medicines-medical-devices-blood/marketing-authorisations-variations-licensing">Marketing authorisations, variations and licensing guidance</a></li>

  </ul>
</nav>

  </div>

  </div>


    </div>
  </div>